Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way.

view original post

Shares of Novo Nordisk and Eli Lilly slipped in premarket trading Wednesday after Roche said it had landed a $5.3 billion deal to develop an obesity-drug candidate.U.S.-listed shares of Novo Nordisk …